Prof. Qian-Qian Chen is an Associate Professor at the School of Pharmacy at Nanjing University of Chinese Medicine, China. He holds a Ph.D. in Pharmacognosy from China Pharmaceutical University, Nanjing. His research focuses on the molecular mechanisms of cardiovascular and renal diseases, the regulatory effects of traditional Chinese medicine (TCM) on disease progression, and the role of the neuraminidase protein family in chronic conditions. Prof. Chen has published extensively in high-impact journals such as Advanced Science, Nature Communications, and European Heart Journal. He is committed to advancing both modern pharmacology and TCM in the context of chronic diseases.
Author Profile
Orcid Profile
🎓EARLY ACADEMIC PURSUITS:
Prof. Qian-Qian Chen began his academic journey with a Bachelor of Science in Pharmacy from Beihua University, Jilin, China, graduating in June 2015. Demonstrating exceptional academic potential, he pursued a Master’s degree in Pharmacy at China Pharmaceutical University, Nanjing, China, from September 2015 to July 2018. He further refined his expertise by completing a Ph.D. in Pharmacognosy at the same university, achieving his doctorate in July 2021.
🏫PROFESSIONAL ENDEAVORS:
Currently serving as an Associate Professor and Master’s Supervisor in Pharmacology at the School of Pharmacy, Nanjing University of Chinese Medicine, Prof. Chen has been in this role since March 2022. His teaching and mentorship significantly contribute to nurturing the next generation of researchers in pharmacology and traditional Chinese medicine (TCM).
🔬CONTRIBUTIONS AND RESEARCH FOCUS ON Pharmacology:
Prof. Chen’s research is primarily centered around the molecular mechanisms underlying cardiovascular and renal diseases. His work focuses on three major areas:
1️⃣ Exploring the molecular pathways involved in cardiovascular and renal disease progression.
2️⃣ Investigating the regulatory effects of traditional Chinese medicine (TCM) on these diseases.
3️⃣ Unveiling the roles and mechanisms of the neuraminidase protein family in chronic conditions, including ventricular remodeling and chronic kidney injury.
His dedication to these fields has yielded a wealth of insights that advance understanding and treatment strategies for complex cardiorenal syndromes.
📈IMPACT AND INFLUENCE:
Prof. Chen has made significant contributions to the scientific community through his publications in prestigious journals. These include:
- Advanced Science (2024)
- Nature Communications (2023)
- European Heart Journal (2021)
- Journal of Ethnopharmacology (2021)
- The American Journal of Chinese Medicine (2021)
- Circulation (2018)
His groundbreaking studies on cardiovascular and renal diseases have been highly cited and praised for their clinical relevance and innovative methodologies.
📚ACADEMIC CITES AND LEGACY:
Prof. Chen’s published work has been widely referenced in the fields of pharmacology, traditional Chinese medicine, and chronic disease research. His studies, particularly those addressing the interplay between cardiovascular and renal systems, serve as a cornerstone for researchers exploring related domains.
🌟FUTURE CONTRIBUTIONS AND VISION:
Looking ahead, Prof. Chen aims to:
- Expand the understanding of traditional Chinese medicine’s regulatory roles in disease mechanisms.
- Advance therapeutic strategies for chronic diseases through interdisciplinary research.
- Mentor emerging researchers, fostering innovation and excellence in pharmacological sciences.
His commitment to merging modern scientific techniques with traditional medicine holds the promise of revolutionary breakthroughs in healthcare.
🌍CONCLUSION:
Prof. Qian-Qian Chen’s impressive academic trajectory, impactful research, and dedication to advancing pharmacology place him as a leading figure in his field. His work not only bridges the gap between traditional and modern medicine but also sets a foundation for transformative discoveries that will benefit patients worldwide.
Top Notable Publications:
Targeting Neuraminidase 4 Attenuates Kidney Fibrosis in Mice
Authors: Qian-Qian Chen
Journal: Advanced Science
Year: 2024
DOI: 10.1002/advs.202406936
Neuraminidase 1 is a Driver of Experimental Cardiac Hypertrophy
Authors: Qian-Qian Chen
Journal: European Heart Journal
Year: 2021
DOI: 10.1093/eurheartj/ehab347
Neuraminidase 1 and its Inhibitors from Chinese Herbal Medicines: An Emerging Role for Cardiovascular Diseases
Authors: Qian-Qian Chen
Journal: The American Journal of Chinese Medicine
Year: 2021
DOI: 10.1142/s0192415x21500403
PMID: 33827385
Untargeted Metabolomics and Lipidomics Uncovering the Cardioprotective Effects of Huanglian Jiedu Decoction on Pathological Cardiac Hypertrophy and Remodeling
Authors: Qian-Qian Chen
Journal: Journal of Ethnopharmacology
Year: 2020
DOI: 10.1016/j.jep.2020.113646
PMID: 33264659
Functional Metabolomics Characterizes a Key Role for N-Acetylneuraminic Acid in Coronary Artery Diseases
Authors: Qian-Qian Chen
Journal: Circulation
Year: 2017
DOI: 10.1161/circulationaha.117.031139
PMID: 29212895